Penn State’s 3D Printed CaroFlex Device Opens a New Front in Drug-Resistant Hypertension

Penn State University researchers have developed a 3D printed bioelectronic device called CaroFlex to treat drug-resistant hypertension, a condition affecting roughly 10% of the 50 million Americans with high blood pressure. The soft, implantable device represents an advancement in additive manufacturing technology applied to medical applications.

Nearly half of all adults in the United States live with hypertension, and for roughly one in ten of them, conventional drug treatments simply don’t work. A research team at Pennsylvania State University (PSU) has developed a potential answer: a soft, 3D printed bioelectronic device that…

This story was originally published by 3D Printing Industry.